ELITech is an in-vitro diagnostic company Hospitals and laboratories in more than 100 countries use ELITech’s products PAI invested in the business in 2017 UPDATED. PAI Partners will hit a 3.7x gross ...
Bruker Corporation BRKR recently entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of the pre-eminent private equity firm PAI Partners, to acquire ...
TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (“ELITech”) for €870 million in cash, excluding the carved out ...
Continuing its aggressive buying spree, Bruker Corp. entered into a definitive share purchase agreement with Tecfin S.à r.l. to acquire molecular diagnostics (MDx) company Elitechgroup SAS for €870 ...
Upon completion of the transaction, ELITech is expected to operate as a stand-alone entity within Bruker’s Microbiology and Infection Diagnostics division. Bruker plans to fund the acquisition with ...
ELITechGroup Clinical Systems features a comprehensive menu of ready-to-use, liquid-stable reagents. Over 100 available assays with flexible reagent packaging and methods referenced to industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback